Letter: Fetal Tissue Research

Alex Weisskopf's exposition in defense of fetal tissue research (The Scientist, Nov. 13, 1989, page 15) was masterful. By applying his suggested guidelines to this "socially sensitive" issue, he assures us we can allay the fears of the public and our own conscience in engaging in fetal tissue research. Not surprisingly, Weisskopf neatly skirted the central issue. His assertion that those who vocally object to the use of abortuses obtained through elective abortion are attempting to force "their

Written byKeith Crutcher
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Alex Weisskopf's exposition in defense of fetal tissue research (The Scientist, Nov. 13, 1989, page 15) was masterful. By applying his suggested guidelines to this "socially sensitive" issue, he assures us we can allay the fears of the public and our own conscience in engaging in fetal tissue research. Not surprisingly, Weisskopf neatly skirted the central issue. His assertion that those who vocally object to the use of abortuses obtained through elective abortion are attempting to force "their religious views into law" is apparently meant to discredit the moral argument against abortion. However, the guidelines that Weisskopf proposes are as "religious" as the premise taken by the "antiabortionist camp," if by that we mean an a priori assumption of ethics or values. Weisskopf makes some remarkable statements along this line. "There is no fundamental moral concept that interdicts the use of fetal tissues." "Fetal tissues . . . are . ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies